• Skip to content
  • Accessibility help
Skip to content
Sign in
  • Guidance
  • Skip Standards and indicators submenu

    Quality standards

    Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.

    View our quality standards

    • How to use our quality standards
    • The timeline for developing quality standards
    • Help us develop quality standards
    • Selecting and prioritising quality standards topics
    • About quality standards

    Indicators

    Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.

    View list of indicators

    • Learn about the committee that develops indicators
    • About indicators
  • Skip Life sciences submenu

    Life Sciences

    We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.

    View life sciences

    Get support from NICE

    NICE Advice service

    Trusted, unrivalled expertise.

    Make an enquiry

    Contact us to discuss your requirements.

    Innovative Licensing and Access Pathway (ILAP)

    Streamlining patient access to safe, financially sustainable and innovative medicines.

    Learn how we evaluate technologies

    Health technology evaluation and topic selection manuals

    Updated manuals for methods, processes and topic selection.

    Digital health technologies

    Accelerating our efforts to deliver innovation to the health and care system.

    Evidence standards framework

    Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.

    Our guidance programmes

    Ensuring new technologies are clinically effective and offer economic value.

    Register your product

    Non-pharmaceutical

    NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.

    Pharmaceutical

    UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.

    Find published and proposed evaluations

    Diagnostics

    Guidance on measurements and tests used to evaluate a patient's condition.

    Medical technologies

    Guidance on medical technologies put forward to NICE by manufacturers.

    Technology appraisals

    Guidance on new and existing medicines and treatments in the NHS.

    Highly specialised technologies

    Guidance on the use of highly specialised medicines and treatments.

  • British National Formulary (BNF)
  • British National Formulary for Children (BNFC)
  • Clinical Knowledge Summaries (CKS)
  • Skip About submenu

    About

    NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.

    Explore about

    Our programmes

    Learn about the information we produce.

    • Guidance
    • Advice
    • Quality standards
    • Indicators
    • Digital health
    • Topic selection

    Get involved

    • Understand how decisions are made:

      Attend a committee meeting
    • Comment on draft guidance:

      Guidance in consultation
    • Be part of a guidance committee:

      Join a committee
    • Help develop our products:

      Register as a stakeholder
    • Putting you at the heart of our work:

      Public involvement

    What we do

    • Social care
    • Life sciences
    • NICE international
    • Patient safety
    • Shared decision making
    • View all What we do

    Into practice

    • Social care quick guides
    • Measuring the use of NICE guidance
    • Resource planner
    • View all Into practice

    Who we are

    • The board
    • The NICE strategy 2021 to 2026
    • Corporate publications
    • View all Who we are

    • Contact us
    • Jobs

My account

  • Consultation responses
  • Sign in

You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Diabetes

Type 2 diabetes in adults: management

  • NICE guideline
  • Reference number: NG28
  • Published:  02 December 2015
  • Last updated:  29 June 2022
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Type 2 diabetes: draft guideline appendices

  • Type 2 Diabetes: appendices A-D

  • Type 2 Diabetes: appendix E

  • Type 2 Diabetes: appendix F

  • Type 2 Diabetes: appendix G

  • Type 2 Diabetes: appendice H-L


This page was last updated: 02 March 2015

  • Equality impact assessment (PDF 132 KB)

    Published:
    02 December 2015
  • Consultation comments and responses (PDF 4.11 MB)

    Published:
    02 December 2015
  • Equality impact assessment (consultation) (PDF 545 KB)

    Published:
    22 July 2015
  • Equality impact assessment (scoping) (PDF 71 KB)

    Published:
    23 July 2015
  • Draft guideline (NICE) (PDF 578 KB)

    Published:
    26 June 2015
  • Full guideline (PDF 4.18 MB)

    Published:
    26 June 2015
  • First consultation comments table with responses (PDF 5.35 MB)

    Published:
    26 June 2015
  • Appendix A (PDF 282 KB)

    Published:
    26 June 2015
  • Appendix B (PDF 320 KB)

    Published:
    26 June 2015
  • Appendix C (PDF 433 KB)

    Published:
    26 June 2015
  • Appendix D (PDF 1.42 MB)

    Published:
    26 June 2015
  • Appendix E (PDF 10.97 MB)

    Published:
    26 June 2015
  • Appendix F (PDF 7.46 MB)

    Published:
    26 June 2015
  • Appendix G (PDF 7.61 MB)

    Published:
    26 June 2015
  • Appendix H (PDF 988 KB)

    Published:
    26 June 2015
  • Appendix I (PDF 3.97 MB)

    Published:
    26 June 2015
  • Appendix J (PDF 4.08 MB)

    Published:
    26 June 2015
  • Appendix K (PDF 205 KB)

    Published:
    26 June 2015
  • Appendix L (PDF 1.81 MB)

    Published:
    26 June 2015
  • Confidentiality form (MSWord 22 KB)

    Published:
    26 June 2015
  • Draft guideline (PDF 4.07 MB)

    Published:
    07 January 2015
  • Draft NICE guideline (PDF 638 KB)

    Published:
    07 January 2015
  • Appendices A-D (PDF 1.82 MB)

    Published:
    07 January 2015
  • Appendix E (PDF 10.97 MB)

    Published:
    07 January 2015
  • Appendix F (PDF 2.84 MB)

    Published:
    07 January 2015
  • Appendix G (PDF 4.98 MB)

    Published:
    07 January 2015
  • Appendice H-L (PDF 5.89 MB)

    Published:
    07 January 2015
  • Health economic plan (PDF 70 KB)

    Published:
    22 October 2014
  • Review questions (PDF 69 KB)

    Published:
    22 October 2014
  • Search strategies (PDF 127 KB)

    Published:
    22 October 2014
  • Registered list of stakeholders (PDF 160 KB)

    Published:
    09 June 2015
  • GDG 14 (PDF 28 KB)

    Published:
    19 June 2015
  • GDG 13 (PDF 90 KB)

    Published:
    21 April 2015
  • GDG 12 (PDF 90 KB)

    Published:
    16 April 2015
  • GDG 11 (PDF 137 KB)

    Published:
    11 December 2014
  • GDG 10 (PDF 143 KB)

    Published:
    17 September 2014
  • GDG 9 (PDF 87 KB)

    Published:
    04 July 2014
  • GDG 8 (PDF 87 KB)

    Published:
    13 May 2014
  • GDG 7 (PDF 141 KB)

    Published:
    04 April 2014
  • GDG 6 (PDF 123 KB)

    Published:
    18 December 2013
  • GDG 5 (PDF 128 KB)

    Published:
    07 November 2013
  • GDG 4 (PDF 126 KB)

    Published:
    09 September 2013
  • GDG 3 (PDF 125 KB)

    Published:
    01 July 2013
  • GDG 2 (PDF 80 KB)

    Published:
    01 July 2013
  • GDG 1 (PDF 99 KB)

    Published:
    28 January 2013
  • GDG membership list (PDF 161 KB)

    Published:
    07 January 2014
  • Final SH comments/developer responses (PDF 838 KB)

    Published:
    16 January 2013
  • Final scope (PDF 147 KB)

    Published:
    07 November 2012
  • Type 1 diabetes (update): draft scope (PDF 82 KB)

    Published:
    04 July 2012
  • Draft scope (PDF 91 KB)

    Published:
    04 July 2012
  • Diabetes in children (update): draft scope (PDF 89 KB)

    Published:
    04 July 2012
  • Diabetes in pregnancy (update): draft scope (PDF 101 KB)

    Published:
    04 July 2012
  • Type 1 Diabetes (update): list of registered stakeholders (PDF 136 KB)

    Published:
    24 March 2015
  • Diabetes in pregnancy (update): list of registered stakeholders (PDF 101 KB)

    Published:
    16 January 2015
  • Diabetes in children and young people: list of registered stakeholders (PDF 129 KB)

    Published:
    24 March 2015
  • Scoping workshop notes (PDF 80 KB)

    Published:
    02 July 2012
Back to top
  • Guidance
  • Standards and indicators
  • Life sciences
  • British National Formulary (BNF)
  • British National Formulary for Children (BNFC)
  • Clinical Knowledge Summaries (CKS)
  • Knowledge resources
  • About NICE
  • Into practice
  • Get involved with NICE
  • Jobs
  • News
  • Newsletters and alerts
  • Contact us
  • Leave feedback
  • Reusing our content
  • NICE UK Open Content Licence
  • Syndicate our content
  • Events
  • Facebook
  • X
  • YouTube
  • LinkedIn
  • Accessibility
  • Freedom of information
  • Glossary
  • Terms and conditions
  • Privacy notice
  • Cookies

© NICE 2025. All rights reserved. Subject to Notice of rights.